Novel compositions containing phosphoglycero ethers, and use thereof for treating neurodegenerative diseases
CA 2199289 C · Owner: L'Institut De Recherche Biologique · Inventors: Forgeot, Marcel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Pharmaceutical compositions relevant to the field of therapeutic chemistry and specifically to the field of phosphoglycerides are disclosed. Said pharmaceutical compositions contain phosphoglycero ethers or plasmalogens partially or predominantly combined with phospholipids derived from polyunsaturated fatty acids having 10-24 carbon atoms and mixed or diluted with inert non-toxic carriers suitable for digestive or parenteral delivery. Said compositions may be used for treating neurodegenerative diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 2, 1996 and granted September 13, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 2, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 2, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.